Skip to main content
. 2014 Dec 3;89(4):2157–2169. doi: 10.1128/JVI.02092-14

FIG 7.

FIG 7

Laboratory-attenuated RABV and wt RABV trans-complemented with G from laboratory-attenuated virus can activate DCs in an IPS-1-dependent manner. (A) Flow-cytometric analysis of the number of CD86-, CD80-, and MHC-II-positive DCs derived from IPS-1 knockout or wild-type mice that were mock treated, infected with CVS-B2c, DRV-Mexico, B2c(DRV-P), B2c(DRV-G), or DRV(B2cG), or treated with LPS or poly(I·C).